-transparent.png){kind=logo}
A radioimmunoassay system for the glycoprotein beta 1SP1, one of the pregnancy-associated proteins, has been set up. beta 1SP1 levels in normal pregnancy have been established transversally. Clearance (t1/2) from the circulation postpartum ranged from 1.4 to 1.8 days. Several patients with trophoblastic disease, e.g., mola hydatidosa, choriocarcinoma and embryonic cell carcinoma, were followed longitudinally. Human chorionic gonadotropin (hCG), a highly reliable tumor marker in trophoblastic disease, has been determined concomitantly by radioimmunoassay. In all instances, hCG proved to be a better indicator of the presence of a tumor, because by the time beta 1SP1 became undetectable, hCG could still be detected. Samples from a large multicenter study on trophoblastic disease were studied: out of 100 positive for hCG, beta 1SP1 could be detected in 86; however, out of 21 samples in which hCG was not detectable, 1 was found to be positive for beta 1SP1. In a number of samples from patients with bronchial carcinoma, no beta 1SP1 could be detected.
L H Elvers, and
G Hiemstra, and
R M Lequin
January 1982,
Clinical chemistry,
L H Elvers, and
G Hiemstra, and
R M Lequin
August 1986,
American journal of obstetrics and gynecology,
L H Elvers, and
G Hiemstra, and
R M Lequin
January 1980,
The Journal of clinical endocrinology and metabolism,
L H Elvers, and
G Hiemstra, and
R M Lequin
September 1969,
American journal of obstetrics and gynecology,
L H Elvers, and
G Hiemstra, and
R M Lequin
January 1983,
Annals of clinical biochemistry,
L H Elvers, and
G Hiemstra, and
R M Lequin
January 1982,
La Ricerca in clinica e in laboratorio,
L H Elvers, and
G Hiemstra, and
R M Lequin
December 1966,
The Journal of clinical endocrinology and metabolism,
L H Elvers, and
G Hiemstra, and
R M Lequin
July 1991,
Akusherstvo i ginekologiia,
L H Elvers, and
G Hiemstra, and
R M Lequin
July 1967,
Obstetrics and gynecology,
L H Elvers, and
G Hiemstra, and
R M Lequin
May 1978,
Lancet (London, England),
